Mechanism of Yiqi Yangying Heluo Formula in the Treatment of IgA Nephropathy by Affecting Gd-IgA1 Based on BAFF Molecular Level and T Lymphocyte Immunity

Table 2

Effect of Yiqi Yangying Heluo Formula on main clinical indicators in patients with IgAN ().

Items	Before treatment	12 weeks of treatment	24 weeks of treatment	48 weeks of follow-up
24 h UTP (g/d) (mean, SD)			^#	^#▲
U-RBC (cells/μL) (mean, SD)			^#	^#
ALB (g/L) (mean, SD)
IgA/C3 (mean, SD)			^#	^#▲
Scr (μmol/L) (mean, SD)
eGFR (mL/min1.73 m^2); (mean, SD)
BUN (mmol/L) (mean, SD)
TC (mmol/L) (mean, SD)
TG (mmol/L) (mean, SD)
ALT (U/L) (mean, SD)
AST (U/L) (mean, SD)
RBC (10^12/L) (mean, SD)
HB (g/L) (mean, SD)
PLT (10^9/L) (mean, SD)
WBC (10^9/L) (mean, SD)

Note: ^∗Compared with the level before treatment, . ^#Compared with the level at 12 weeks of treatment, . ^▲Compared with the level at 24 weeks of treatment, . 24 h UTP: 24-hour urinary protein; U-RBC: urinary red blood cell; ALB: serum albumin; Scr: serum creatinine; eGFR: estimated glomerular filtration rate; BUN: blood urea nitrogen; TC: serum total cholesterol; TG: serum triglyceride; ALT: serum alanine aminotransferase; AST: serum aspartate aminotransferase; RBC: red blood cell; HB: hemoglobin; PLT: platelet; WBC: white blood cell.